Literature DB >> 12384416

Activation of Rac-1, Rac-2, and Cdc42 by hemopoietic growth factors or cross-linking of the B-lymphocyte receptor for antigen.

Brock Grill1, John W Schrader.   

Abstract

Interleukin-3 (IL-3)-induced activation of endogenous Rac-1, Rac-2, and Cdc42. Rac-1 was also activated by colony-stimulating factor-1 (CSF-1), Steel locus factor (SLF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-5 or by cross-linking the B-lymphocyte receptor for antigen (BCR). The activation of Rac-1 induced by cross-linking the BCR or by IL-3 stimulation was blocked only partially by Ly294002, with about 25% to 30% of Rac-1 activation still occurring in the absence of detectable increases in phosphatidyl-inositol-3 kinase (PI-3K) activity. Overexpression of constitutively active mutants of H-Ras, N-Ras, or M-Ras resulted in activation of coexpressed Rac-1 through an Ly29402-resistant, PI-3K-independent mechanism. Overexpression of constitutively active mutants of p21 Ras, or Rac-1, but not of PI-3K, was sufficient for activation of p38 mitogen-activated protein kinase (MAPK) in cells of hemopoietic origin. Inhibition of increases in PI-3K activity by Ly294002 had no effect on the IL-3-induced activation of p38 MAPK. In contrast, Ly294002 partially inhibited the activation of p38 MAPK induced by cross-linking of the BCR, although some p38 MAPK activation occurred in the absence of increases in the activity of Rac-1 or PI-3K. The activation of Rac-1, Rac-2, and Cdc42 by IL-3 and other hemopoietic growth factors is likely to be an important component of their actions in promoting growth, survival, and function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384416     DOI: 10.1182/blood-2002-01-0154

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Regulation of Rac1 and Cdc42 activation in thrombin- and collagen-stimulated CHRF-288-11 cells.

Authors:  Bing Xu; Rajinder P Bhullar
Journal:  Mol Cell Biochem       Date:  2011-03-16       Impact factor: 3.396

2.  Differential role of reactive oxygen species in the activation of mitogen-activated protein kinases and Akt by key receptors on B-lymphocytes: CD40, the B cell antigen receptor, and CXCR4.

Authors:  Rosaline L Lee; Jens Westendorf; Michael R Gold
Journal:  J Cell Commun Signal       Date:  2007-05-10       Impact factor: 5.782

3.  Rho GTPase Cdc42 is essential for B-lymphocyte development and activation.

Authors:  Fukun Guo; Chinavenmeni S Velu; H Leighton Grimes; Yi Zheng
Journal:  Blood       Date:  2009-08-11       Impact factor: 22.113

4.  A hot-spot mutation in CDC42 (p.Tyr64Cys) and novel phenotypes in the third patient with Takenouchi-Kosaki syndrome.

Authors:  Midori Motokawa; Satoshi Watanabe; Akiko Nakatomi; Tatsuro Kondoh; Tadashi Matsumoto; Kanako Morifuji; Hirotake Sawada; Toyoki Nishimura; Hiroyuki Nunoi; Koh-Ichiro Yoshiura; Hiroyuki Moriuchi; Sumito Dateki
Journal:  J Hum Genet       Date:  2018-01-15       Impact factor: 3.172

5.  Rac1/2 activation promotes FGFR1 driven leukemogenesis in stem cell leukemia/lymphoma syndrome.

Authors:  Tianxiang Hu; Yating Chong; Sumin Lu; Meaghan McGuinness; David A Williams; John K Cowell
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

Review 6.  ROS and ROS-Mediated Cellular Signaling.

Authors:  Jixiang Zhang; Xiaoli Wang; Vikash Vikash; Qing Ye; Dandan Wu; Yulan Liu; Weiguo Dong
Journal:  Oxid Med Cell Longev       Date:  2016-02-22       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.